# Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

> **NCT03897192** · — · COMPLETED · sponsor: **Changhua Christian Hospital** · enrollment: 14 (actual)

## Conditions studied

- Punctate Inner Choroidopathy

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT03897192
- **Lead sponsor:** Changhua Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-03-20
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03897192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03897192, "Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03897192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*